Shanghai Haoyuan Chemexpress Co.Ltd(688131) board of directors
Description of confidentiality measures and systems adopted in this transaction Shanghai Haoyuan Chemexpress Co.Ltd(688131) (hereinafter referred to as “the company”) intends to provide information to Wang Yuan (Wang Yuan), Shanghai Yuanmeng enterprise management consulting partnership (limited partnership), Qidong Yuanli enterprise management consulting partnership (limited partnership) Ningbo Jiusheng innovative pharmaceutical technology Co., Ltd. issued shares and paid cash to purchase 100% equity of YaoYuan Pharmaceutical Chemistry (Shanghai) Co., Ltd. it plans to issue shares to Shanghai anxio Information Technology Co., Ltd., the controlling shareholder, to raise supporting funds (hereinafter referred to as “this transaction”).
In view of the possible fluctuation of the company’s stock price caused by this transaction, in order to avoid the adverse impact on this transaction caused by too many participants, disclosing and divulging relevant information, the company has adopted strict confidentiality measures and systems for this transaction. The details are as follows:
1. This transaction strictly controls the scope of project participants and reduces the scope of personnel who know the sensitive information related to this transaction as much as possible.
2. When the trading parties contact, the company and the counterparty have taken necessary and sufficient confidentiality measures, limited the scope of insiders of relevant sensitive information, and registered the insiders of insider information.
3. The company has repeatedly informed the insiders of the inside information to strictly abide by the confidentiality system and fulfill the confidentiality obligation. Before the disclosure of the inside information according to law, the company shall not disclose or disclose the inside information, nor use the inside information to buy and sell the company’s shares or suggest others to buy and sell the company’s shares.
4. In accordance with relevant regulations, the company has prepared a memorandum on the transaction process of major asset restructuring and the registration of insiders, and reported relevant materials to Shanghai stock exchange for filing.
In conclusion, the company has taken necessary and sufficient confidentiality measures in this transaction, formulated a strict and effective confidentiality system, limited the scope of knowledge of relevant sensitive information, and strictly fulfilled the confidentiality obligation of this transaction information before disclosure according to law.
It is hereby explained.
Shanghai Haoyuan Chemexpress Co.Ltd(688131) board of directors March 5, 2022
